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Anemia occurs when the number of healthy red blood cells is insufficient to meet the body’s physiological needs for oxy-gen delivery to the brain, heart, muscles and other vital tis-
sues. Hemoglobin is the primary oxygen-carrying molecule within 
red blood cells, so anemia is most typically measured in terms of 
hemoglobin content of the blood rather than red blood cell vol-
ume1,2. Anemia can reduce cognitive and physical capacities and 
is associated with reduced economic productivity3,4 and increased 
morbidity and all-cause mortality5. Maternal iron deficiency can 
lead to adverse pregnancy and newborn outcomes, including still-
birth, low birth weight and infant mortality6, and anemia in preg-
nancy has been suggested as a potential marker of increased risk of 
major hemorrhage7 and a risk factor for maternal death8.
Causes of anemia can be divided into three non-mutually exclu-
sive pathways: blood loss, increased red blood cell destruction and 
inadequate red blood cell production. Blood loss can be acute due 
to events such as injuries, maternal hemorrhage or surgery, or it 
can be chronic, due to conditions such as gastrointestinal disor-
ders, helminthic infections, bleeding disorders or abnormal uter-
ine bleeding9,10. Increased red blood cell destruction happens either 
as a consequence of abnormal red blood cell structure, such as in 
thalassaemia or sickle cell disease, or because of external mechani-
cal, immune or infectious factors11. Inadequate production of red 
blood cells can happen when the bone marrow itself is depressed, 
such as in HIV12 or some malignancies; because there are hor-
monal imbalances, such as with chronic inflammation;13 or due 
to increased demand (such as during pregnancy), nutrient malab-
sorption or inadequate supply of red blood cell building blocks, 
such as protein, iron, vitamin A14, folate or vitamin B-12 (ref. 15) 
Iron deficiency is often thought of as the most common cause of 
anemia, which is true but also misleading, because absolute and/or 
functional iron deficiency can arise as a consequence of any of the 
three pathways and, therefore, as a consequence of multiple differ-
ent causes. Women of reproductive age (WRA; ages 15–49 years) 
are at particularly increased risk of iron deficiency and, therefore, 
anemia, compared to men, due to physiological changes such as 
menstruation (blood loss pathway), pregnancy (inadequate pro-
duction pathway due to increased demand) and bleeding in child-
birth16,17. Additionally, unequal household food allocation can 
make WRA vulnerable to anemia as they might not have access to 
iron-rich foods17.
Anemia continues to affect millions of women worldwide and 
remains concentrated in LMICs as defined by the Global Burden 
of Disease (GBD) Socio-Demographic Index (SDI)18. In 2019, 
30.1% of WRA were estimated to have anemia globally, with wide 
geographical variation18, and dietary iron deficiency was among 
the highest-ranking conditions in both prevalence and years lived 
with disability (YLDs) among WRA in LMICs19. The WHO has set 
a GNT to reduce anemia in WRA by 50% by 2025 (refs. 2,20); this 
target and other related WHO GNTs have since been extended to 
2030 (ref. 21). In October 2019, the percentage of WRA with ane-
mia was officially added as an indicator to track progress toward the 
Sustainable Development Goal (SDG) 2.2 to end all forms of mal-
nutrition by 2030 (refs. 22,23). Although the WHO provides national- 
level anemia estimates and tracking tools, available reports do not 
show the subnational heterogeneity needed to inform within-count ry 
planning, annual changes to track progress or anemia severity 
stratifications20,24. Maps of comparable estimates across space and 
time at policy-relevant administrative levels are vital to identify the 
most vulnerable populations, track progress toward international 
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anemia goals and provide decision-makers and policy-makers with 
tools to aid targeted interventions.
This study is part of a series using high-spatial-resolution esti-
mates to map progress toward the WHO GNTs25–27. To perform 
this study, we compiled an extensive geo-positioned dataset from 
218 surveys representing over 3 million women. Using Bayesian 
model-based geostatistics and the assumption that locations with 
similar socioeconomic and environmental patterns and proximity 
in time and space would have similar anemia levels, we produced 
estimates for all areas across 82 LMICs, even where data were sparse. 
The geospatial nature of our estimates also allows for the flexibility 
to aggregate to different (and sometimes changing) boundaries and 
catchment areas over the observation period.
Here we present annual geospatial estimates from 2000 to 2018 
of prevalence and absolute counts of anemia of WRA (non-pregnant 
and pregnant combined), stratified by severity and aggregated to 
first-level (for example, provinces) and second-level (for example, 
districts) administrative units and national levels across 82 LMICs. 
Overall anemia was defined as <12 g dl−1 for non-pregnant WRA 
and <11 g dl−1 for pregnant WRA28. Anemia severity categories are 
defined by the WHO: mild anemia (11.0–11.9 g dl−1 for non-pregnant 
WRA; 10.0–10.9 g dl−1 for pregnant WRA), moderate anemia (8.0– 
10.9 g dl−1 for non-pregnant WRA; 7.0–9.9 g dl−1for pregnant WRA) 
and severe anemia (<8.0 g dl−1 for non-pregnant WRA; <7.0 g dl−1 for 
pregnant WRA). We also discuss our results in light of public health 
problem thresholds: no public health problem (<5% overall anemia 
prevalence), low public health problem (5–19.9% overall anemia prev-
alence), medium public health problem (20–39.9% overall anemia 
prevalence) and high public health problem (≥40% overall anemia 
prevalence)28. We show annualized rates of change (AROCs) between 
2000 and 2018 and estimate the probability of achieving the WHO 
GNT by 2025 and 2030 based on recent trends. Additionally, we pro-
vide subnational disparity analyses. These estimates can aid in focusing 
attention on exemplars of progress, highlighting subnational inequal-
ities and identifying locations requiring further investments. The full 
suite of outputs from the analysis are publicly available on the Global 
Health Data Exchange (http://ghdx.healthdata.org/record/ihme-data/
global-anemia-prevalence-geospatial-estimates-2000-2019) and via 
our interactive data visualization tool (https://vizhub.healthdata.org/
lbd/aneamia).
results
Prevalence and trends of overall anemia. The prevalence of over-
all anemia among WRA varied broadly across LMICs (Fig. 1a,b). 
In 2018, anemia prevalence was highest in West African, Middle 
Eastern and South Asian countries, including Gambia (50.3% (95% 
uncertainty interval: 43.3–57.5)), Senegal (47.3% (43.4–50.1)), Mali 
(47.6% (45.8–49.4)), Yemen (57.4% (50.9–63.8)) and India (49.9% 
(47.2–52.4)). The lowest national-level anemia prevalence in 2018 
was found in Central America and the Caribbean, Andean South 
America and East Asia, including El Salvador (8.2% (3.6–16.1)), 
Colombia (9.2% (4.5–17.0)), Mexico (10.4% (7.3–15.3)) and China 
(11.1% (9.1–13.1)).
Gradual declines on a global scale indicate that little progress 
was seen in reducing anemia on a more local scale. Across the 82 
LMICs, overall anemia among WRA decreased from 35.6% (25.7–
46.9) in 2000 to 31.6% (25.2–39.1) in 2018. High levels of anemia 
remained widespread in 2018, with just over half (56.1%; 46 of 82) 
of LMICs with 20–39.9% prevalence of mean national-level overall 
anemia in 2018. On a subnational scale, 80 (97.6%) LMICs had at 
least one second administrative-level unit (hereafter ‘district’), and 
38 (46.3%) LMICs had a majority of districts with 20–39.9% mean 
overall anemia prevalence. Over a quarter of LMICs (25.6%; 21 
LMICs) had >40% mean national-level anemia in 2018, whereas 76 
(92.7%) had at least one district, and 22 (26.8%) LMICs had most of 
their districts, with >40% mean overall anemia prevalence.
Anemia was at unacceptable levels (>5% prevalence)28 in 99.7% 
(21,868 of 21,917) of districts across LMICs in 2000 and 98.9% 
(21,686 of 21,917) in 2018. (Fig. 1a,b). In 2000, 30.7% (6,725 of 
21,917), 48.9% (10,726 of 21,917) and 20.1% (4,417 of 21,917) of 
subnational districts had low (5–19.9%), medium (20–39.9%) and 
high (≥40%) public health threat levels of anemia among WRA28, 
respectively (Extended Data Table 1). Global shifts led to 37.7% 
(8,273 of 21,917), 43.5% (9,523 of 21,917) and 17.7% (3,881 of 
21,917) of districts having low, medium and high public health 
problem levels in anemia prevalence among WRA, respectively, 
in 2018. Only two countries (Peru and Ecuador) had districts that 
maintained levels below 5% prevalence of overall anemia in both 
2000 and 2018. In Peru, 36 of 195 (19.5%) districts had overall ane-
mia prevalence levels <5% in both 2000 and 2018, such as in San 
Román (Puno) in the south (2.3% (1.1–4.3) in 2000; 0.4% (0.2–0.7) 
in 2018); in Ecuador, only one of 223 (0.4%) districts mean esti-
mates achieved <5% prevalence in both years: the centrally located 
Cevallos (Tungurahua) (4.4% (1.0–12.5) in 2000; 4.6% (1.2–11.4) in 
2018). Although Mexico had 16 districts and Iran had two districts 
below public health problem levels (<5%) in 2000, these districts 
exceeded 5% overall anemia prevalence in 2018. In 2018, only nine 
LMICs had at least one district with no public health problem in 
anemia (<5%), including Bolivia (two of 114 districts), Colombia 
(13 of 1,065 districts), Ecuador (one of 223 districts), El Salvador 
(six of 266 districts), Guatemala (87 of 354 districts), Mexico (25 of 
2,454 districts), Thailand (one of 928 districts) and Uganda (two of 
203 districts). Peru has seen great success reducing childhood stunt-
ing29, in part due to its targeted focus on those most in need—the 
poor, the more disadvantaged and rural populations—and some of 
this progress is mirrored in its low rates of anemia as demonstrated 
by half of its districts (57.9%; 113 of 195) having less than 5% mean 
overall anemia prevalence in 2018.
With few exceptions, we see that countries with the subnational 
units with the best anemia prevalence rates in 2000 continue to have 
administrative units that perform well in 2018, and likewise for 
countries with the worst-performing subnational units. To illustrate 
where these high and low pockets continue to be most pervasive 
and how their rates of change contribute to maintaining this relative 
status, we overlaid the highest and lowest deciles for prevalence (Fig. 
1a,b) and AROCs (Fig. 1d) for overall anemia among WRA across 
LMICs to simultaneously show the best- and worst-performing dis-
tricts as defined by both of these measures over the study period 
(Fig. 1c). Much of Central and South America had districts with the 
lowest levels of prevalence of overall anemia in 2000 and 2018, with 
some areas experiencing the largest decreases over time (largest 
AROCs), including in western Colombia and central and southern 
Peru. Much of Mexico and El Salvador, as well as districts in western 
Honduras, central Ecuador and select districts in eastern Brazil, also 
had among the lowest prevalence levels in both years, whereas west-
ern Bolivia and western Guatemala experienced some of the largest 
declines in the period that led to their place among the lowest decile 
of anemia prevalence in 2018. Within these same countries, how-
ever, there were also districts with the highest prevalence levels and/
or largest increases or stagnating trends in anemia (smallest AROC) 
between 2000 and 2018. Districts in southern Mexico, eastern 
Honduras, eastern Venezuela and eastern Colombia had among the 
lowest prevalence levels in 2000, but increases pushed these districts 
out of the lowest prevalence decile by 2018. Eastern Guatemala, 
eastern Ecuador and northern Bolivia had among the highest preva-
lence levels in both 2000 and 2018. In Asia, northern Vietnam and 
large stretches of China experienced some of the largest declines 
and had the lowest levels of anemia prevalence. Districts through-
out Uzbekistan, Pakistan, India and Papua New Guinea and in 
northern Myanmar, however, saw the highest consistent prevalence, 
and the centers of Laos and India and parts of Afghanistan expe-
rienced among the largest increases or stagnating trends (smallest 




























































































Fig. 1 | Prevalence and ArOCs of overall anemia in WrA (2000–2018). a, b, Prevalence of overall anemia among WrA (ages 15–49) at the second 
administrative unit (for example, district) level in 2000 (a) and 2018 (b). c, Overlapping population-weighted highest and lowest (10th and 90th deciles) 
prevalence and ArOcs between 2000 and 2018. Largest ArOc indicates where largest decreases in overall anemia prevalence from 2000 to 2018 
occurred, whereas smallest ArOc indicates where the largest increases (or smallest decreases or stagnation) in overall anemia prevalence from 2000 
to 2018 occurred. d, Weighted annualized percentage of change of overall anemia prevalence in WrA from 2000 to 2018. Maps reflect administrative 
boundaries, land cover, lakes and population; gray-colored grid cells had fewer than ten people per 1 × 1-km grid cell and were classified as ‘barren or 
sparsely vegetated’, whereas white-colored grid cells were not included in this analysis42–47.
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the historical baseline and in spite of the observed increased preva-
lence of mild anemia. This is further corroborated by the remain-
ing 13,915 districts, which experienced decreases in moderate, 
severe and mild anemia. Among the districts that saw increases in 
prevalence of moderate and severe anemia (15.9%; 3,476 of 21,917), 
91.3% (3,175 of 3,476 in 57 LMICs) experienced increases in overall 
anaemia, indicating a population-wide shift toward reduced hemo-
globin levels. This was seen particularly in Yemen and Nigeria, 
where 81.7% (272 of 333) and 68.8% (533 of 775) of their districts, 
respectively, saw increases in overall, moderate and severe anemia. 
In contrast, only 276 districts saw increases in moderate and severe 
anemia but decreases in overall anemia, possibly indicating a sub-
population that has been left behind while the majority trend is 
toward non-anemic hemoglobin levels. Of note, Papua New Guinea 
and Burkina Faso experienced this divergent trend where 11.5% 
(10 of 87) and 11.1% (5 of 45) of their districts, respectively, saw 
increases in the prevalence of moderate and severe anemia while 
overall anemia decreased. Our stratified maps of the highest- and 
lowest-decile districts for prevalence and AROC for mild, moderate 
and severe anemia offer a detailed view of these shifts in severity 
across and within LMICs over time (Extended Data Fig. 1).
Absolute and relative geographic inequalities of anemia. In addi-
tion to the overall trend toward lower levels of anemia prevalence, 
the heterogeneity of district-level anemia prevalence and, thus, sub-
national inequality has decreased over the last two decades. By plot-
ting the absolute geographic inequalities (Fig. 3a), we show the range 
of overall anemia prevalence among each country’s districts in 2000 
and 2018. Subnational inequalities between districts with the high-
est and lowest anemia prevalence in each country have increased 
in most (65.9%; 54 of 82) LMICs over the study period. Absolute 
inequalities among districts as well as national median anemia 
prevalence increased in six countries during the period from 2000 
AROC). Several African countries had among the highest levels of 
anemia in both years, including Senegal, Mali, Côte d’Ivoire, eastern 
Ghana, southern Benin, central Niger, Nigeria, Gabon, Democratic 
Republic of the Congo, Tanzania, Kenya, Ethiopia, Somalia, Malawi, 
Mozambique, Zimbabwe and Egypt, and the belt across the Sahel 
witnessed some of the worst stagnation. No African districts ranked 
among the lowest decile of anemia prevalence, but there were areas 
in Ethiopia, Tanzania, Democratic Republic of the Congo, South 
Africa and a few other select districts that experienced some of the 
fastest decreases.
Overall, 71 (86.6%) LMICs experienced decreases in mean ane-
mia prevalence in most of their districts over the 2000–2018 period, 
and seven (8.5%) LMICs (Cape Verde, China, Kyrgyzstan, Malaysia, 
Namibia, Tunisia and Turkmenistan) had annualized improve-
ments (declines) in all districts. Increases in overall anemia preva-
lence were experienced in the majority of districts in nine LMICs 
(Burundi, Central African Republic, Côte d’Ivoire, Gabon, Gambia, 
Nigeria, Republic of the Congo, Tajikistan and Yemen), and no 
countries experienced increases in all their districts. Many countries 
experienced extreme differences in their rates of change across their 
subnational units: 57 (69.5%) LMICs had at least 2.5% annualized 
decreases and increases across their districts, whereas 18 (22.0%) 
LMICs had districts with at least 5% AROC in both directions.
Prevalence and trends of anemia by severity. Mean prevalence of 
moderate and severe anemia had reduced in the majority (84.1%; 
18,441 of 21,917) of districts across LMICs between 2000 and 2018 
(Fig. 2). In almost a quarter of the districts in which moderate 
and severe anemia had declined (24.5%; 4,526 of 18,441 across 79 
LMICs), mild anemia had increased, indicating a downward shift 
in severity levels over the populations. Among these, three-quarters 
(76.0%; 3,476 of 4,562) saw decreases in overall anemia, suggesting 
















































































Fig. 2 | Prevalence of anemia in WrA by severity in LMICs (2000 and 2018). a–f, Prevalence of anemia stratified by severity among WrA (ages 15–49) 
at the second administrative unit (for example, district) level. Prevalence of mild anemia among WrA in 2000 (a) and 2018 (d). Prevalence of moderate 
anemia among WrA in 2000 (b) and 2018 (e). Prevalence of severe anemia among WrA in 2000 (c) and 2018 (f). See Supplementary table 7 for the 
cutoffs defining mild, moderate and severe anemia. Maps reflect administrative boundaries, land cover, lakes and population; gray-colored grid cells had 
fewer than ten people per 1 × 1-km grid cell and were classified as ‘barren or sparsely vegetated’, whereas white-colored grid cells were not included in this 
analysis42–47.
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that, in 2000, overall anemia prevalence varied across the national 
level by as much as 5.8-fold (9.5% (6.4%–13.7%) in El Salvador; 
55.5% (41.4%–69.4%) in Gabon), and, in 2018, overall anemia varied 
by as much as 7.0-fold at the national level (8.2% (3.5%–16.3%) in El 
Salvador; 57.4% (51.4%–63.5%) in Yemen). Within-country relative 
inequalities in overall anemia increased in 63 LMICs between 2000 
and 2018, with some of the most apparent deviations in Guatemala, 
Venezuela, Colombia, Ecuador, Bolivia, Thailand, Ethiopia, Egypt 
and Tajikistan; 19 LMICs experienced decreases in relative inequali-
ties, including Iran, Vietnam, Palestine and Sudan. Although many 
of the countries with large subnational disparities in anemia preva-
lence could use the results from this study to efficiently target preci-
sion public health interventions where they are most needed, there 
is a second set of countries that had low subnational inequalities 
and high national prevalence, indicating a pervasive problem where 
ubiquitous intervention coverage is warranted. In 2018, among the 
21 countries that qualified as high public health problems with a 
national mean overall anemia prevalence above 40%, four of these 
countries had low relative inequalities ranging from 75% to 125% 
of the national median: Gabon, Guinea-Bissau, Republic of Congo 
and Senegal.
Population size, severity and disability burden of anemia. Of the 
estimated 1.2 billion WRA across the 82 LMICs represented by our 
analysis in 2000, we estimate that 378.3 million (95% uncertainty 
interval: 308.0–456.0) (32.8% (26.7–39.5)) of WRA were anemic 
(Extended Data Fig. 2a). Of these, 178.4 million (134.6–231.8) or 
to 2018: Yemen (2.4-fold to 2.6-fold difference; 51.7% (34.0–68.6%) 
to 63.0% (50.9–74.3%) national median prevalence); Gambia 
(1.2-fold to 1.5-fold difference; 52.7% (30.4–74.7%) to 637.4% 
(47.4–66.2%)); Nigeria (2.0-fold to 3.4-fold difference; 36.1% (17.4–
58.4%) to 44.8% (37.2–66.2%)); Central African Republic (1.3-fold 
to 1.6-fold difference; 35.0% (19.5–53.5%) to 36.2% (20.4–54.2%)); 
El Salvador (3.3-fold to 5.0-fold difference; 9.2% (4.6–16.8%) to 
9.5% (3.1–21.4%)); and Gabon (1.4-fold to 1.5-fold difference; 
51.0% (32.2–70.5%) to 51.2% (33.8–67.9%)). Although absolute 
inequalities had also increased in the other 48 LMICs, national 
median anemia prevalence decreased in these countries, indicating 
select exemplar districts that made progress and/or districts that 
were left behind in national progress. Overall, 28 LMICs reduced 
absolute inequalities as well as their national median anemia preva-
lence; most notably, China had reduced absolute inequalities from 
5.6-fold to 4.7-fold across its districts, reducing its national median 
from 18.8% (10.2–30.9%) to 11.4% (4.4–22.7%) between 2000 and 
2018. In 2000, 19 LMICs experienced ≥3-fold difference in overall 
anemia, and six LMICs experienced ≥6-fold difference in overall 
anemia (Afghanistan, Ecuador, Iran, Mexico, Peru and Vietnam); 
in 2018, 30 LMICs had ≥3-fold difference, and 11 LMICs had 
≥6-fold difference, across districts (Bolivia, Colombia, Ecuador, 
Ethiopia, Guatemala, Honduras, Kenya, Mexico, Peru, Uganda and 
Venezuela) (Supplementary Table 10).
Our relative inequality plot shows the relative deviation of each 
country’s districts from their national mean anemia prevalence 
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Fig. 3 | Geographical inequality in overall anemia among WrA across 82 countries for 2000 and 2018. a, Absolute inequalities: range of overall anemia 
estimates in WrA in second administrative-level units within 82 LMIcs. b, relative inequalities: range of ratios of overall anemia estimates in WrA in 
second administrative-level units relative to country means (administrative level/country level). Each dot represents a second administrative-level unit. 
the lower bound of each bar represents the second administrative-level unit with the lowest overall anemia in WrA in each country. the upper end of 
each bar represents the second administrative-level unit with the highest overall anemia in WrA in each country. thus, each bar represents the extent 
of geographic inequality in overall anemia in WrA estimated for each country. bars indicating the range in 2018 are colored according to their GbD 
super-region48 (Extended Data Fig. 3). Gray bars indicate the range in overall anemia in WrA in 2000. the black diamond in each bar represents the 
median and mean overall anemia in WrA estimated across second administrative-level units in each country and year for the absolute (median) and 
relative (mean) inequalities plots. A colored bar that is shorter than its gray counterpart indicates that geographic inequality has narrowed.
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districts that had more than 250,000 anemic WRA each were in 
22 LMICs: Angola, Bangladesh, Brazil, Burkina Faso, Cameroon, 
China, Côte d’Ivoire, Democratic Republic of the Congo, Ethiopia, 
Ghana, Haiti, India, Indonesia, Madagascar, Morocco, Myanmar, 
Nepal, Pakistan, Peru, South Africa, Tanzania and Togo. Across the 
1,545 first administrative-level units (hereafter ‘provinces’) in the 
82 LMICs, 66 provinces located in 12 LMICs (Angola, Bangladesh, 
Brazil, China, Ethiopia, India, Indonesia, Myanmar, Nepal, Nigeria, 
Pakistan and South Africa) each had 1 million or more anemic 
WRA in 2018. All five of the provinces with the highest estimated 
number of WRA with anemia in 2018 were in India and Pakistan: 
Uttar Pradesh in India (29.0 million (26.3–31.5)), Bihar in India 
(15.8 million (14.4–17.1)), West Bengal in India (15.5 million (14.4–
16.6)), Maharashtra in India (15.4 million (13.4–17.2)) and Punjab 
in Pakistan (12.6 million (6.8–18.8)).
Stratifying by severity, an estimated 57.9% (55.1–60.9) of mod-
erately or severely anemic WRA lived in only three countries in 
2018: India (103.4 million (94.2–112.7) cases; 46.1% (41.9–50.8%) 
of moderate or severe WRA anemia cases), Pakistan (13.4 mil-
lion (8.5–19.0) cases; 6.0% (4.6–7.1%)) and China (13.0 million 
(10.2–16.5) cases; 5.8% (5.5–6.1%)) (Fig. 4c,d). We found that 133 
districts had more than 250,000 WRA with moderate or severe 
anemia in 2018, located in nine LMICs: Bangladesh (two districts), 
Brazil (one district), China (one district), Côte d’Ivoire (one dis-
trict), Democratic Republic of the Congo (one district), India (118 
districts), Nepal (one district), Pakistan (seven districts) and Peru 
47.2% (43.7–50.8) were categorized as having mild anemia, whereas 
182.4 million (138.1–234.5) or 48.2% (44.9–51.4) were moderate 
anemia cases, and 17.4 million (11.2–26.3) or 4.6% (3.6–5.8) were 
severe anemia cases (Extended Data Fig. 2b–d). In 2018, of the 1.5 
billion WRA represented by our analysis, 449.1 million (382.4–
526.9) (30.4% (25.9–35.6)) were estimated to be anemic—224.8 
million (180.9–275.7) (50.1% (47.3–52.3%)) with mild cases of ane-
mia, 208.1 million (173.1–247.3) (46.3% (45.3–46.9)) with moder-
ate cases of anemia, and 16.1 million (12.2–21.3) (3.6% (3.2-4.0)) 
with severe cases of anemia (Fig. 4a–d).
A large proportion of anemic WRA were concentrated in a few 
countries in 2018; 83.0% (81.0–85.3) of overall anemia occurred 
in the Asian (61.7% (60.9–62.9)) and sub-Saharan African (21.3% 
(20.1–22.4)) regions (Fig. 4a). An estimated 59.6% (55.6–63.2) of 
anemic WRA, amounting to an estimated 267.5 million (241.5–
293.2) cases across LMICs, lived in just four countries in 2018: 
India (181.3 million (171.4–190.2) cases; 40.4% (36.1–44.8) of 
anemia burden), China (39.5 million (32.3–46.9); 8.8% (8.9–8.5)), 
Pakistan (23.8 million (15.3–32.6); 5.3% (4.0–6.2)) and Nigeria 
(23.0 million (22.5–23.5); 5.1% (5.9–4.5)). In 2018, we estimated 
that 65.2% (14,292 of 21,917) of districts contained fewer than 
5,000 anemic WRA, 14.6% (3,199 of 21,917) with 5,000–14,999, 
12.4% (2,716 of 21,917) with 15,000–49,999, 4.5% (991 of 21,917) 
with 50,000–150,000 and 1.7% (377 of 21,917) with 150,000–
250,000, and 1.7% (374 of 21,917) had more than 250,000 WRA 
































































































































































































Fig. 4 | Counts and YLDs by anemia severity among WrA across LMICs in 2018. a–d, Number of WrA across 82 LMIcs with overall (a), mild (b), 
moderate (c) and severe (d) anemia in 2018 by second administrative-level units. e–h, Number of YLDs among WrA attributable to overall (e), mild 
(f), moderate (g) and severe (h) anemia in 2018 by second administrative-level units. Maps reflect administrative boundaries, land cover, lakes and 
population; gray-colored grid cells had fewer than ten people per 1 × 1-km grid cell and were classified as ‘barren or sparsely vegetated’, whereas 
white-colored grid cells were not included in this analysis42–47.
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(16 of 117), China (2 of 364), Colombia (123 of 1,065), Ecuador (1 
of 223), El Salvador (32 of 266), Guatemala (179 of 354), Honduras 
(13 of 298), Mexico (31 of 2,454), Peru (120 of 195), Rwanda (3 of 
30), Thailand (28 of 928), Uganda (4 of 203), Venezuela (1 of 338) 
and Vietnam (1 of 710). Based on current projections, we expect 
that 21 LMICs will maintain high national levels of overall anemia 
(≥40%) in 2030; on a subnational scale, 16.4% (3,594 of 21,917) of 
districts located in 61 LMICs are estimated to have ≥40% anemia 
prevalence in 2030 if existing trajectories continue.
Assuming that recent trends persist, and using the year 2012 (the 
year that WHO GNTs were established) as a baseline, we estimated 
the probability of subnational units across LMICs achieving the 
WHO GNT to relatively reduce anemia by 50% by the year 2030 
(Fig. 5b). By 2030, only three of the 82 (3.7%) LMICs in this analysis 
are expected to achieve the target of 16.2% at a national scale with 
a high probability (>95% posterior probability): China, Iran and 
Thailand. Subnationally, however, no countries have a high prob-
ability of meeting the WHO GNT for anemia in all provinces, nor 
in all their districts, by the target year. About a third (31.7%; 26 of 
82) of LMICs have a high probability (>95%) of meeting the target 
in at least one district, whereas only three LMICs (Guatemala, Iran 
and Peru) have a high probability of meeting the goal in most dis-
tricts. We expect far more LMICs to have a low probability (<5% 
posterior probability) of achieving the target nationally and subna-
tionally. By 2030, 64.6% (53 of 82) of LMICs have a low probability 
(<5%) of meeting the WHO GNT nationally, whereas 21.2% (18) 
have a low probability in all provinces, and four LMICs (Gabon, 
Gambia, Senegal and Togo) have a low probability of meeting the 
target in all their districts. Although 15 (18.3%) LMICs have a >50% 
probability of achieving the WHO GNT by 2030 nationally, five 
(6.1%) LMICs have >50% probability of achieving the target in all 
their province-level units, and only Tunisia has >50% probability of 
meeting the goal in all its district-level units by 2030.
Large inequalities in achieving the WHO GNT are expected to 
continue, and 56.1% (46 of 82) of LMICs are predicted to have dis-
tricts with both >50% and <50% probability of meeting the goal 
by 2030. We estimate that 20 LMICs have districts with both high 
probability (>95%) and low probability (<5%) of achieving the 
WHO GNT by 2030.
Discussion
Marginal declines in anemia prevalence among WRA in LMICs 
have left individuals, populations and nations at risk of reduced 
economic productivity3,4, increased all-cause mortality5 and 
increased potential for adverse outcomes for mothers and new-
borns31. Although most district-level units (80.5%; 17,651 of 21,917 
districts) decreased their prevalence between 2000 and 2018, the 
overall prevalence among the 82 LMICs in our analysis has only 
declined, from 35.6% (95% uncertainty interval: 25.9–46.6) to 31.6% 
(25.7–38.2) in the nearly 20-year period. Even for the many coun-
tries with overall improvements in reducing anemia prevalence, 
our results highlight enduring disparities across global geographic 
regions and within select countries and subnational locations that 
have stagnated or fallen behind the general improvements of their 
neighbors. Although three LMICs (China, Iran and Thailand) have 
a high probability of meeting the WHO GNT of reducing anemia 
among WRA by 50% by the year 2030, no LMIC is predicted to 
meet the target in all provinces or all districts. Most LMICs (64.6%; 
53 LMICs) have a low probability (<5%) of meeting the target even 
on a national scale. Broad inequalities are expected to continue into 
2030; we estimate that 20 LMICs have districts with a high prob-
ability of meeting the target as well as districts with a low probabil-
ity of meeting the target. Furthermore, population growth during 
this period has led to substantial increases in the number of WRA 
affected by anemia in various locations. Although the overall num-
ber of prevalence of anemia in WRA has decreased, growing popu-
(one district). The five provinces with the highest estimated num-
bers of moderate or severe WRA in 2018 were also all in India and 
Pakistan: Uttar Pradesh in India (16.7 million (14.7–19.0)), Bihar 
in India (9.4 million (8.4–10.5)), Maharashtra in India (8.2 million 
(6.7–9.8)), West Bengal in India (8.1 million (7.2–9.2)) and Punjab 
in Pakistan (6.9 million (3.7–10.6)).
Multiplying counts in each anemia severity category with the 
appropriate disability weights from the GBD study30 allowed us to 
visualize where the majority of YLDs (attributable burden) due to 
anemia among WRA have been most concentrated in LMICs and 
how it has reduced over time (Extended Data Fig. 2e–h and Fig. 
4e–h). Overall anemia contributed 12.7 million (5.9–22.2) YLDs 
in 2000, with 0.7 million (0.3–1.1), 9.4 million (4.7–15.4) and 2.6 
million (0.9–5.7) YLDs from mild, moderate and severe anaemia, 
respectively (Extended Data Fig. 2e–h). By 2018, YLDs had increased 
to 14.0 million (9.0–20.4) overall; mild, moderate and severe ane-
mia increased to 0.8 million (0.5–1.3), 10.7 million (7.2–15.1) and 
reduced to 2.4 million (1.3–4.1) YLDs, respectively (Fig. 4e–h). In 
2018, 0.7% (145 of 21,917) of districts each contributed more than 
15,000 YLDs due to overall anemia among WRA; these districts 
were in just nine LMICs: Bangladesh, Brazil, China, Côte d’Ivoire, 
Democratic Republic of the Congo, India, Nepal, Pakistan and Peru. 
Districts with over 5,000 YLDs attributed to overall anemia among 
WRA (3.1% (677 of 21,917)) were in 33 LMICs. The three countries 
with the most YLDs from overall anemia among WRA in 2018 were 
India (6.43 million (5.80–7.11) YLDs), Pakistan (0.85 million (0.53–
1.21) YLDs) and China (0.83 million (0.65–1.06) YLDs). In 2018, 
532 of 21,917 districts across 30 LMICs contributed more than half 
of YLDs (7.0 million (4.8–9.6)) attributed to overall anemia across 
the 82 LMICs in this analysis.
Between 2000 and 2018, the majority of districts across LMICs 
experienced reductions in estimates of YLDs attributable to moder-
ate anemia (54.1%; 11,859 of 21,917 districts) and severe anemia 
(67.9%; 14,876 of 21,917 districts) among WRA (Extended Data Fig. 
2g,h and Fig. 4g,h). This progress in reducing YLDs due to moder-
ate and severe anemia was especially evident in China (1.74 mil-
lion (1.40–2.17) YLDs in 2000 and 0.74 million (0.57–0.95) in 2018; 
declines in 359 of 364 districts). In 10,078 districts located across 
all 82 LMICs, however, YLDs from moderate anemia increased, 
including in 12 countries where all districts experienced increases: 
Burkina Faso, Chad, Côte d’Ivoire, Guinea-Bissau, Jordan, Mali, 
Pakistan, São Tomé and Príncipe, Senegal, Sierra Leone, Somalia and 
Yemen. The YLDs from severe anemia increased in 7,061 districts 
across 79 LMICs, including in Yemen (332 of 333 districts), Burkina 
Faso (44 of 45 districts), Chad (53 of 55 districts) and Jordan (48 
of 52 districts). The district with the largest increase in YLDs from 
moderate anemia was Bangalore (Karnataka) in India, with 23,003 
(7,665–44,041) YLDs in 2000 and 43,497 (30,063–57,816) YLDs 
in 2018. The largest increase in YLDs from severe anemia was in 
Bijnor (Uttar Pradesh) in India, with 791 (282–1,627) YLDs in 2000 
and 6,884 (4,767–9,476) YLDs in 2018.
Prospects of meeting 2030 WHO GNT. We applied the estimated 
AROCs to the final year of our estimates to predicted anemia preva-
lence estimates for the year 2030 (Fig. 5a). In 2018, 29 of 21,917 
districts had >80% mean prevalence of overall anemia; if current 
trends continue, 100 districts across Guatemala (11 districts), Haiti 
(seven districts), India (two districts), Nigeria (four districts) and 
Yemen (76 districts) are estimated to reach >80% mean prevalence 
for overall anemia among WRA by 2030. Subnational inequalities in 
Guatemala are expected to continue, and, although 17 northeastern 
districts are projected to reach >75% prevalence by 2030, 179 south-
western districts are expected to reduce to below 5% prevalence, 
considered acceptable levels of anemia. Including Guatemala, we 
estimate that districts in 15 LMICs will have less than 5% prevalence 
in overall anemia by 2030: Afghanistan (1 of 399 districts), Bolivia 
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micronutrient supplementation for pregnant women in LMICs 
might provide additional benefits of reducing low-birth-weight 
outcomes, small-for-gestational-age outcomes and preterm birth 
outcomes32. Universal antenatal hemoglobin testing can help iden-
tify anemic women early, providing time to investigate causality 
and eliminate anemia before delivery33. In endemic areas, malaria 
control has demonstrated over 25% and 60% reduction in overall 
anemia and severe anaemia, respectively16. Countries with high lev-
els of anemia and malaria34, such as Mali, Democratic Republic of 
the Congo, Papua New Guinea, Pakistan and India, might benefit 
from increased malaria control efforts. Proper water and sanitation, 
including safe water and education on hand-washing and hygienic 
disposal of fecal matter, can reduce infection risks and related nutri-
tional losses2. Additionally, the association between intestinal hel-
minths and anemia, due to nutritional theft and direct blood loss, 
has led the WHO35 to recommend de-worming pregnant women in 
helminth-endemic areas. LMICs with co-distribution of helminths36 
and high prevalence of anemia include Nigeria, Madagascar, 
Bangladesh and Papua New Guinea. A variety of intervention 
delivery platforms could be used, including regular routine ante-
natal care visits, community health workers and community-based 
social marketing16. Strategies and delivery platforms should be 
context-specific and tailored for populations based on the local cul-
ture and disease burden; these estimates provide policy-makers the 
opportunity to ‘aim to ensure the most vulnerable members of the 
populations are reached’16. For those with chronic conditions, such 
lations have caused the number of anemic WRA to increase from 
378.3 million to 449.1 million, with the largest increases in Central 
Asia and western, central and eastern sub-Saharan Africa (54.7% 
increase: 20.2–31.3 million; 88.0% increase: 24.6–46.2 million; 
53.1% increase: 7.6–11.6 million; and 51.8% increase: 20.9–31.8 
million, respectively), offsetting the large decreases seen in East 
Asia and Andean South America (44.1% decrease: 70.9–39.6 mil-
lion and 13.7% decrease: 5.6–4.8 million, respectively).
The multitude of different diseases and injuries, nutritional and 
behavioral risk factors and sociodemographic factors that can lead 
to anemia mandate inter- and multi-sectorial approaches involv-
ing stakeholders and actors in the public and private sectors and 
coordination across food systems and health-related sectors if 
large-scale reductions in anemia prevalence are to be achieved2,16. 
GBD 2019 estimated the top-ranked global causes of anemia in 
WRA to be, in order, dietary iron deficiency; thalassaemia trait; 
sickle cell trait; menstrual disorders; endocrine, metabolic, blood 
and immune disorders; and malaria19, although the specific cause 
composition varied by country and age group. Regardless of anemia 
prevalence levels, the WHO recommends a diet with adequate bio-
available iron and iron folate and micronutrient fortification of rice 
and flours where they are major staples16. Intermittent or daily iron 
and folic acid supplementation is recommended for WRA depend-
ing on pregnancy and postpartum status, menstruation, tuberculo-
sis diagnosis and population-level prevalence, with key prevalence 


















































Fig. 5 | Prevalence for overall anemia among WrA in 2030 and probability of achieving the WHO GNt for overall anemia by 2030. a, Predicted 
prevalence of overall anemia among WrA in 2030 by second administrative-level units. b, Probability of achievement of the WHO GNt to reduce overall 
anemia in WrA by 50% by the year 2030, with the year 2012 as a baseline, by second administrative-level units. Maps reflect administrative boundaries, 
land cover, lakes and population; gray-colored grid cells had fewer than ten people per 1 × 1-km grid cell and were classified as ‘barren or sparsely 
vegetated’ or were not included in this analysis42–47.
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of anemia to track with the underlying causes of anemia. Similarly, 
prevalence and count maps of all-anemia burden can be used to 
target hotspots but are not sufficient to determine the best course 
of treatment for those communities. Neither the uncertainty from 
resampling polygonal data to point data, nor the uncertainty from 
modeled covariates, were accounted for in our models. Uncertainty 
plots of the outputs in our models can be found in Supplementary 
Figs. 10–13 and 16. We expect that propagating the uncertainty 
from the resampling and the modeled covariates would increase the 
overall uncertainty in our estimates. In contrast, if we were able to 
incorporate the assessment technique (venous versus capillary) or 
the processing technique, we expect that accounting for these possi-
ble confounders would decrease the uncertainty of these estimates.
The large global burden of anemia continues to underline the 
need for high-resolution estimates to track progress toward inter-
national targets and to aid policy-makers in targeting interventions 
and scarce resources. The recent addition of anemia reduction as a 
target for the Sustainable Development Goal 2 further highlights the 
global importance of the issue22,23. This study details the subnational 
trends in anemia prevalence in WRA across 82 LMICs, broken 
down by severity, and highlights the local differences in burden and 
progress within and between countries. The results and the interac-
tive visualizations presented in this study provide an unprecedented 
opportunity for policy-makers and health institutes to examine the 
variation in anemia prevalence and its historical progress within 
their communities and can aid targeting of further data collection, 
limited resources and interventions to populations most in need.
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Methods
Overview. This study implemented continuous geostatistics modeling of 
mild, moderate and severe anemia prevalence over time, from which local-, 
administrative- and national-level estimates of prevalence, counts and all 
other estimated quantities were derived. An ensemble approach using a 
Bayesian generalized linear mixed effects model was used to embed non-linear 
algorithmically predicted mean functions within a Gaussian process framework, 
assumed to have a correlated space–time covariance structure. We sampled 
1,000 draws from an approximate posterior distribution of this model and 
generated annual prevalence estimates for mild, moderate, and severe anemia 
prevalence of WRA (ages 15–49 years) on an approximate 5 × 5-km grid over 
82 LMICs from 2000 to 2018 and performed population-weighted aggregation 
of these gridded estimates to administrative and national levels. Countries 
were selected for inclusion in this study using the SDI, a summary measure of 
development that combines education, fertility and poverty18. Selected countries 
were in the low, lower-middle and middle SDI quintiles, with several exceptions 
(Supplementary Table 3). China, Malaysia and Turkmenistan were included 
despite high-middle SDIs for geographic continuity with other included countries. 
Albania, Bosnia-Herzegovina, North Korea and Moldova were excluded due to 
geographic discontinuity and lack of available survey data. Of this set of countries, 
we did not generate estimates for 26 countries, as no survey data could be sourced 
(Supplementary Table 4).
Data. Surveys and hemoglobin data. We extracted each individual woman’s 
hemoglobin concentrations (g L−1), age, pregnancy status, smoking status and 
elevation from household series, including the Demographic and Health Surveys, 
the Multiple Indicator Cluster Surveys, the Living Standards Measurement Study 
and the Core Welfare Indicators Questionnaire, among other country-specific child 
health and nutrition surveys. Included across our models were 218 geo-referenced 
household surveys from 2000 to 2018 representing over 3 million WRA. Each 
individual woman’s record was associated with a cluster, a group of neighboring 
households or a ‘community’ that acted as a primary sampling unit in the survey 
design. The 218 surveys with hemoglobin, pregnancy, smoking and elevation data 
included geographic coordinates or precise place names for each cluster within 
that survey. In the absence of geographic coordinates for each cluster, we assigned 
data to the smallest available administrative areal unit in the survey (polygon) 
while accounting for the survey sample design49. Boundary information for these 
administrative units was obtained as shapefiles either directly from the surveys or 
by matching to shapefiles in the Global Administrative Unit Layers database42 or 
the Database of Global Administrative Areas (GADM)50. In select cases, shapefiles 
provided by the survey administrator were used, or custom shapefiles were created 
based on survey documentation. Using methods from our previous works38, 
these areal data were resampled to point locations using a population-weighted 
sampling approach over the relevant areal unit with the number of locations 
set proportionally to the number of grid cells in the area and the total weights 
of all the resampled points summing to 1. In addition, some data sources did 
not contain hemoglobin concentrations and, instead, reported only the anemia 
severity category. These severity categories were used directly, whereas hemoglobin 
concentrations were adjusted and thresholded as described in the following 
section.
Select data sources were excluded for the following reasons: missing survey 
weights for areal data, missing sex or age variable, incomplete sampling (for 
example, only women aged 20–24 years measured) or untrustworthy data (as 
determined by the survey administrator or by inspection). Data availability plots for 
anemia by country, data type and year can be found in Supplementary Figs. 1–5.
Hemoglobin adjustments and anemia severity. For the purpose of defining 
anemia severity status, hemoglobin concentrations are often first adjusted 
for individual smoking status and residential elevation28. Many data sources 
provide some combination of raw hemoglobin, smoking-adjusted hemoglobin, 
elevation-adjusted hemoglobin and smoking- and elevation-adjusted hemoglobin 
concentrations. Wherever possible, this study started with the raw hemoglobin 
concentrations and performed both smoking and elevation adjustments, as 
suggested by the WHO. If only partially adjusted (either only smoking-adjusted or 
elevation-adjusted), we performed the second adjustment, and, if only completely 
adjusted hemoglobin concentrations were available, we used those. The elevation 
adjustments are shown in Supplementary Table 5, and the smoking adjustments are 
shown in Supplementary Table 6.
Once the hemoglobin concentrations had been doubly adjusted for smoking 
and elevation, they were then thresholded into non-anemic, mild anaemia, 
moderate anaemia or severe anaemia categories using the WHO definitions shown 
in Supplementary Table 7. Some data sources reported only the anemia severity 
categories, which were then used directly in the modeling stage. After classification 
into anemia severity categories, individual-level data observations were then 
collapsed to cluster-level totals for the number of WRA sampled and total number 
of WRA who were determined to be mildly, moderately or severely anemic.
Temporal resolution. We estimated the prevalence of mild, moderate and severe 
anemia annually from 2000 to 2018 using a model that allowed us to account 
for data points measured across survey years and, as such, allows us to predict 
at monthly or finer temporal resolutions. We were limited, however, both 
computationally and by the temporal resolution of covariates and, thus, have 
produced annual estimates (Supplementary Table 8 and Supplementary Fig. 8).
Spatial covariates. A variety of socioeconomic and environmental variables were 
used to predict anemia. Where available, the finest spatio-temporal resolution 
of gridded datasets was used. These covariates were selected based on their 
potential to be predictive for anemia and the pathways to anemia, including certain 
nutritional deficiencies, according to literature review and plausible hypothesis 
as to their influence. Acquisition of temporally dynamic datasets, where possible, 
was prioritized to closely align with our observations and to predict the changing 
dynamics of the anemia severity indicators.
We used covariate-driven predictive models to leverage strength from locations 
with observations to the entire spatial-temporal domain. Several 5 × 5-km raster 
layers of putative socioeconomic and environmental correlates of anemia were 
compiled and used as covariates across the 82 LMICs in the modeling domain 
(Supplementary Table 8 and Supplementary Fig. 8). These covariates were selected 
based on their potential to be predictive for anemia and the pathways to anemia, 
including certain nutritional deficiencies, according to literature review and 
plausible hypothesis as to their influence. Acquisition of temporally dynamic 
datasets, where possible, was prioritized to closely align with our observations 
and to predict the changing dynamics of the anemia severity indicators. Of the 
19 covariates included, 12 were temporally dynamic and were re-formatted as a 
mid-year estimate or synoptic mean for each year in the estimation period. These 
included average diurnal temperature range, average potential evapotranspiration, 
average daily mean rainfall (precipitation), outdoor air pollution (PM2.5), 
educational attainment in WRA (ages 15–49 years), enhanced vegetation index, 
tasselled cap brightness, prevalence of underweight (ages 0–5 years), Healthcare 
Access and Quality Index, fertility, urbanicity and population. The remaining 
seven covariate layers were static throughout the study period and were applied 
uniformly across all modeling years; these covariates included growing season 
length, irrigation, nutritional yield for vitamin A, nutritional yield for zinc, 
nutritional yield for iron, distance to rivers and lakes and travel time to nearest 
settlement with more than 50,000 inhabitants.
Travel time to nearest settlement, nutritional yield for vitamin A, nutritional 
yield for iron and nutritional yield for zinc were selected because of their potential 
to be predictive for anemia and the pathways to anemia. Fertility, malaria 
incidence, population, outdoor air pollution and prevalence of underweight were 
selected for inclusion in modeling owing to their correlation with a wide variety 
of health-related outcomes. Average daily mean temperature, average daily mean 
rainfall, irrigation, land cover, multi-source weighted-ensemble precipitation 
and tassled cap brightness were selected for their correlation with a variety of 
crop yields. In addition, the stacking methodology used in this study boosts the 
predictive performance of individual covariates by leveraging non-linear and 
high-order interactions among the covariates and generally performs better when 
given a variety of covariates.
Analysis. Geostatistical model. To model the full distribution of possible indicators 
of anemia status—that is, all, mild, moderate and severe anemia—we used an 
ordinal modeling approach51 to estimate the relative proportion of each indicator.
We implemented a continuation ratio model to estimate the prevalence of 
three categories: mild, moderate and severe. We first modeled the proportion of all 
anemia within a Bayesian hierarchical framework using logistic regression with a 
spatially and temporally explicit generalized linear mixed effects model. Second, 
we modeled the probability of being mildly anemic conditional on being anemic 
(that is, being mildly, moderately or severely anemic) using the same Bayesian 
modeling framework. Finally, we modeled the probability of being severely anemic 
conditional on being either moderately or severely anemic. The estimates from the 
two conditional models were combined with the all-anemia estimates to compute 
the marginal prevalence of mild, moderate and severe anemia.
For each modeling region, at each cluster, d, where d = 1, 2, …n, and time t, 
where t = 2000, 2001, …, 2018, the prevalence of all anemia was modeled using the 
observed number of WRA in cluster d who were found to be anemic as a binomial 
count, Cd, among an observed sample of Nd:




∀ observed clusters d
logit (pi,t) = β0 + Xi,tβ + Zi,t + ϵctr(i)
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For indices d,i and t, *(index) is the value of * at the index. The annual 
prevalence of all anemia, pi,t, in spatial location i, in time t, was modeled as a 
linear combination of the three submodels (generalized additive model, boosted 
regression trees and lasso regression), rasterised covariate values, Xi,t, a correlated 
spatio-temporal random effect term Zi,t, country random effects ϵctr(i), with one 
unstructured country random effect fit for each country in the modeling region 
(Extended Data Fig. 3) and all ϵctr sharing a common variance parameter, γ2, and 
an independent nugget random effect, ϵi,t, with variance parameter σ2. Coefficients 
βh in the three submodels h∈1,2,3 represent their respective predictive weighting 
in the logit-link, whereas the joint structured process, Zi,t, accounts for residual 
spatio-temporal autocorrelation among individual data points that remain after 
accounting for the predictive effect of the submodel covariates, the country-level 
random effect, ϵctr(i), and the nugget, ϵi,t. The spatio-temporal residual process, Zi,t, 
was modeled as a three-dimensional Gaussian process in space–time centerd at 0 
and with a covariance matrix constructed from a Kronecker product of spatial and 
temporal covariance kernels. The spatial covariance, Σspace, was modeled using an 
isotropic and stationary Matérn function52 and the temporal covariance, Σtime, as an 
annual autoregressive (AR1) function over the 19 years represented in the model. 
In the stationary Matérn function, the covariance between two spatial locations 
that are Euclidean distance D apart is a function of Γ, the gamma function, Kv, 
the modified Bessel function of the second kind of order v > 0, κ > 0, a scaling 
parameter and ω2, the marginal variance. The scaling parameter, κ, is defined to 
be κ =
√
8v/δ, where δ is the range parameter (interpreted to be the approximate 
distance at which the correlation between two locations drops to 0.1), and v is a 
scaling constant, which is set to 2 rather than fit from the data. The number of rows 
and the number of columns of the spatial Matérn covariance matrix are both equal 
to the number of spatial mesh points for a given modeling region. The Matérn 
kernel is a practical and common choice that can flexibly model a wide variety of 
spatial surfaces and allows for fitting or selection of the smoothness of the surface, 
helping to avoid unrealistic over-smoothing52. For the temporal kernel, we chose 
to use an AR1 process owing to its stability, which aligns well with the observed 
relatively slow and smooth changes in anemia prevalence across time, and for its 
interpretability. In the AR1 function, ρ is the temporal correlation between adjacent 
time steps, taken to be single years in this study, and k and j are time steps. The 
number of rows and the number of columns of the AR1 covariance matrix are both 
equal to the number of temporal mesh points (19). The number of rows and the 
number of columns of the space–time covariance matrix, Σspace ⊗ Σtime, for a given 
modeling region are equal (the number of spatial mesh points × the number of 
temporal mesh points). Previous sensitivity analyses on these models showed these 
modeling choices to be generally quite robust37,53.
This approach leverages the residual correlation structure to more accurately 
predict prevalence estimates for locations with no data while also propagating 
the dependence in the data through to uncertainty estimates54. The posterior 
distributions were fit using computationally efficient and accurate approximations 
in R-INLA55 (integrated nested Laplace approximation) with the stochastic partial 
differential equations (SPDE)56 approximation to the spatio-temporal Gaussian 
process using R version 3.5.1. The SPDE approach using INLA was demonstrated 
elsewhere, including the estimation of health indicators, particulate air matter 
and population age structure56. Uncertainty intervals were generated from 
1,000 draws (that is, statistically plausible candidate maps)57 created from the 
posterior-estimated distributions of modeled parameters.
Mesh construction. We constructed the finite elements mesh for the SPDE 
approximation to the Gaussian process regression using a simplified polygon 
boundary (in which coastlines and complex boundaries were smoothed) for 
each of the regions within our model. We set the inner mesh triangle maximum 
edge length (the mesh size for areas over land) to be 0.75 degrees and the buffer 
maximum edge length (the mesh size for areas over the ocean) to be 5.0 degrees58. 
An example finite elements mesh constructed for eastern sub-Saharan Africa mesh 
can be found in Supplementary Fig. 7.
Post-estimation. To transform grid cell-level estimates into a range of information 
useful to a wide constituency of potential users, these estimates were aggregated 
at first and second administrative units specific to each country and at national 
levels40. Although the models can predict all locations covered by available raster 
covariates, all final model outputs for which land cover was classified as ‘barren or 
sparsely vegetated’ on the basis of Moderate Resolution Imaging Spectroradiometer 
satellite data (2013) were masked59. Areas where the total population density was 
fewer than ten individuals per 1 × 1-km grid cell in 2015 were also masked in 
the final outputs. To compute the YLDs, we applied the corresponding disability 
weights from the GBD study30 on prevalence estimates of the severity bins (mild, 
moderate and severe anemia) and summed to get the total YLDs for all anemia.
Model validation. Models were validated using spatially stratified five-fold 
out-of-sample cross-validation. To replicate real-world missingness in the 
datasets and to fairly assess model performance in areas far from observed data, 
acknowledging the spatial correlation inherent in the observation, holdout folds 
were created by combining sets of all data falling within first administrative-level 
units. Validation was performed by calculating bias (mean error), variance 
(root-mean-square error), 95% data coverage within prediction intervals and 
correlation between observed data and predictions. All validation metrics were 
calculated on the out-of-sample predictions from the five-fold cross-validation. All 
validation procedures and corresponding results are provided in Supplementary 
Tables 17–19 and Supplementary Figs. 20–22.
In-sample metrics. To assess the in-sample performance of our models and compare 
to national-level estimates produced by the GBD study, we generated a suite of 
diagnostic plots for anemia estimates in each of the regions and countries modeled. 
To explore residual error over space and time, absolute error (data minus predicted 
posterior mean estimates at the corresponding grid cells) was produced.
Metrics of predictive validity. To assess the predictive validity of our estimates, 
we validated our models using spatially stratified five-fold out-of-sample 
cross-validation60. To construct each spatial fold, we used a modified bi-tree 
algorithm to spatially aggregate data points. This algorithm recursively partitions 
two-dimensional space, alternating between horizontal and vertical splits on the 
weighted data sample size medians, until the data contained within each spatial 
partition are of a similar sample size. The depth of recursive partitioning is 
constrained by the target sample size within a partition and the minimum number 
of clusters or pseudo-clusters allowed within each spatial partition (in this case, a 
minimum sample size of 500 was used). These spatial partitions are then allocated 
to one of five folds for cross-validation. For validation, each geostatistical model 
was run five times, each time holding out data from one of the folds, generating a 
set of out-of-sample predictions for the held-out data. A full suite of out-of-sample 
predictions over the entire dataset was generated by combining the out-of-sample 
predictions from the five cross-validation runs.
Using these out-of-sample predictions, we then calculated mean error (or bias), 
root-mean-squared error (RMSE, which summarizes total variance), coefficient of 
variation (defined to be the standard deviation divided by the mean and multiplied 
by 100, which is a measure of relative variability) and 95% coverage of our 
predictive intervals (the proportion of observed out-of-sample data that fall within 
our predicted 95% credible intervals) aggregated up to different administrative 
levels (levels 0, 1 and 2) as defined by the GADM50. Administrative level 0 (admin 
0) borders correspond to national boundaries; administrative level 1 (admin 1) 
borders generally correspond to regions, provinces or state-level boundaries within 
a country; and administrative level 2 (admin 2) borders correspond to the next 
finer subdivision, often districts, within regions. These metrics are summarized in 
Supplementary Tables 13–15 and Supplementary Figs. 15–17 and are calculated 
across all regions. Included in the sample tables for comparison are the same 
metrics calculated on in-sample predictions.
Sensitity analysis. We ran four five-fold cross-validation holdout in-sample 
experiments, using different combinations of covariates and random effects:
 1. Raw covariates + Gaussian process: logit (pi) = β0 + Xiβraw + ϵGPi + ϵi
 2. Raw covariates: logit (pi) = β0 + Xiβraw + ϵi
 3. Stacking predictions as covariates: logit (pi) = β0 + Xiβstack + ϵi
 4. Stacking covariates + Gaussian process (standard model): 
logit (pi) = β0 + Xiβstack + ϵGPi + ϵi
The summary error measures for all models are shown in Supplementary Figs. 
20 and 21 to demonstrate how adding stackers or the Gaussian process individually 
change predictive capacity on administrative level 1 and 2, respectively. Across 
the two levels of aggregation and all four validation metrics, the models with 
a Gaussian process outperformed those without, as they had smaller RMSE 
and greater correlation. For the standard model, which used both the stacking 
covariates and the Gaussian process, the in-sample RMSE and correlation were 
0.053 and 0.078 and 0.87 and 0.77 at administrative levels 1 and 2, respectively. 
For the raw covariates model with the Gaussian process, RMSE = 0.069 and 0.084, 
and the correlation = 0.71 and 0.63; for the model that used raw covariates only, 
RMSE = 0.066 and 0.091, and the correlation = 0.55 and 0.43; and for the stacked 
covariates model, RMSE = 0.056 and 0.079, and the correlation = 0.85 and 0.75, at 
administrative levels 1 and 2, respectively.
Projections. To compare our estimated rates of improvement in all-anemia 
prevalence over the 19-year period across different locations, and to assess if 
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locations are on track to meet the WHO GNT for anemia given historical rates of 
improvement, we performed a simple projection using estimated AROCs applied 
to the final year of our estimates. Both AROCs and projections were calculated at 
the draw level to construct uncertainty estimates for both.
For all-anemia prevalence, we calculated AROCs at each administrative-level 





We then calculated a weighted AROC for all-anemia by taking a weighted 
average across the years, where more recent AROCs were given more weight in the 
average. We defined the weights to be:
Wt =
(t − 2000)γ
Σ20182001 (t − 2000)γ
,
where γ may be chosen to give varying amounts of weight across the years. Using 
the weights and the AROCs between consecutive years, the average AROC across 






Finally, we calculated the projections (Proj) by applying the 7 years of the 
AROC (from 2018 to 2025) to our mean 2018 prevalence estimates. The projection 
was performed in logit-space (consistent with the AROC calculation) to ensure 
that the projected estimates range between 0 and 1:
Proja,2025 = logit−1 (logit (pa,2018) + AROCa × 7) .
This projection scheme is analogous to the methods used in the GBD 2017 
measurement of progress and projected attainment of health-related SDGs18. The 
exponential power in the weighting scheme was chosen to match that used by 
the GBD study, which selects this parameter using an out-of-sample predictive 
validation framework. Our projections assume that areas will sustain the current 
AROC, and the precision of the AROC estimates is dependent on this assumption 
and the uncertainty from the all-anemia annual prevalence estimates.
Post-estimation calibration to national and subnational estimates. To leverage 
national-level data that were included in GBD 2017 (ref. 18) but were outside the 
scope of our current geospatial modeling framework, and to ensure alignment 
between this study’s estimates and GBD 2017 estimates, we performed a post 
hoc calibration to each of our 1,000 candidate maps. For each posterior draw, we 
calculated population-weighted grid cell aggregations at the level of GBD estimates 
(at national or subnational level) and compared these estimates in each year to 
the analogous and available GBD 2017 estimates from 2000 to 2017. We defined 
the raking factor to be the ratio between the GBD 2017 estimates and our current 
estimates and linearly interpolated raking factors in each country between the 
available years. Finally, we multiplied each of our grid cells in a country-year by its 
associated raking factor. This ensures alignment between our geospatial estimates 
and GBD 2017 estimates while preserving our estimated within-country geospatial 
and temporal variation.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
The findings of this study are supported by data available in public online 
repositories, data publicly available upon reasonable request of the data provider and  
data not publicly available owing to restrictions by the data provider. Non-publicly 
available data were used under licence for the current study but might be available 
from the authors upon reasonable request and with permission of the data provider. 
A detailed table of data sources and availability can be found in Supplementary 
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Extended Data Fig. 1 | Highest- and lowest-performing second administrative-level units stratified by anaemia severity in women of reproductive age 
across LMICs (2000–2018). a–d, Overlapping population-weighted highest and lowest deciles of prevalence and weighted annualised rates of change 
(ArOc) by severity at the second administrative level between 2000 and 2018 for overall (a), mild (b), moderate (c), and severe anaemia (d) among 
WrA. Maps reflect administrative boundaries, land cover, lakes, and population; grey-coloured grid cells had fewer than ten people per 1 × 1-km grid cell 
and were classified as “barren or sparsely vegetated”, while white-coloured grid cells were not included in this analysis42–47.
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Extended Data Fig. 2 | Counts and years lived with disability (YLDs) by anaemia severity among WrA in 2000. a–d, Number of WrA across 82 
LMIcs with overall (a), mild (b), moderate (c), and severe anaemia (d) in 2000 by second administrative-level units. e–h, Number of years lived with 
disability (YLDs) among women of reproductive age (WrA) attributable to overall (e), mild (f), moderate (g), and severe anaemia (h) in 2000 by second 
administrative-level units. Maps reflect administrative boundaries, land cover, lakes, and population; grey-coloured grid cells had fewer than ten people per 
1 × 1-km grid cell and were classified as “barren or sparsely vegetated”, while white-coloured grid cells were not included in this analysis42–47.
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Extended Data Fig. 3 | Modelling regions. Modelling regions48 were based on geographic and Socio-demographic Index (SDI) regions from the Global 
burden of Disease18, defined as Andean South America, central America and the caribbean, central sub-Saharan Africa (SSA), East Asia, Eastern SSA, 
Middle East, North Africa, Oceania, Southeast Asia, South Asia, South SSA, central Asia, tropical South America, and Western SSA. regions in grey (Stage 
3) were not included in our models due to high-middle and high SDI. Only 82 low- and middle-income countries (LMIcs) were included in this study.
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Extended Data Fig. 4 | Modeling process flow diagram. the geospatial modelling process consists of three main sections. First, all available survey 
data that can be referenced to a coordinate/point (for example, survey cluster) or small polygon (administrative) unit are compiled, Hb measurements 
are converted to anaemia severity, data matched to polygons are resampled into pseudo-points, covariates are merged onto the point-level dataset, a 
series of conditional geospatial model is fit using stacked generalization child models as main effects is fit for each geographic region, and 1000 posterior 
predictions are sampled from the fitted model. Second, the 1000 parameter draws are projected into 1000 5x5km pixel conditional prevalence candidate 
maps, converted into marginal anaemia severity prevalence maps, calibrated to GbD 2019 estimates, and aggregated to administrative levels. Lastly, 
the 1000 calibrated pixel and aggregated draws are summarized into estimates of anaemia prevalence, counts, YLDs, and the associated uncertainty, 
probabilities of meeting targets, and rates of change. See the Methods for more details.
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